LATS2 and neoplasm: Hippo signaling controlled the expression of genes of the MHC-I antigen processing and presentation pathway, and loss of LATS1 and LATS2, critical kinases required for Hippo signaling activation, favors tumor immune evasion through decreasing MHC-I expression (38, 39).